Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 320 participants.

Also called NCT02834221

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 320 participants (enrolled count) (from the registry)
Sponsor
Kenichiro Yamagata (from the registry)
Registry
  • NCT NCT02834221
Main results
  • Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: a multicentre randomized efficacy and safety trial (ULTRA-FAST trial) Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2018-07-01 DOI, PubMed 28575490

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia, Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02834221. Randomized; single masking; primary purpose prevention. Start 2016-06 (registry gives no type); primary completion 2016-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment
Acronym
ULTRA-FAST
Condition
Peripheral Vascular Disease
Condition
Vascular Access Complications
Intervention (Device)
Real-time ultrasound-guided puncture
Intervention (Other)
Anatomical landmark guided puncture
Lead sponsor
Kenichiro Yamagata (class: other government)

Record details

Record id
cardio:ct-nct02834221
Content hash
6992cfb0d256bc8a8550908bc45336cfb33c1d7b3cc51e06ac0c3aa8a5b7f80c